Pages that link to "Q40614406"
Jump to navigation
Jump to search
The following pages link to Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma (Q40614406):
Displaying 32 items.
- Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor (Q22009108) (← links)
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11 (Q28250083) (← links)
- Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs (Q34999736) (← links)
- VIP as a trophic factor in the CNS and cancer cells (Q35063187) (← links)
- Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist (Q35226241) (← links)
- Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis (Q35295564) (← links)
- Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma (Q35535797) (← links)
- GABA and Gi/o differentially control circadian rhythms and synchrony in clock neurons (Q35539848) (← links)
- A molecular model for intercellular synchronization in the mammalian circadian clock (Q35794588) (← links)
- Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design (Q36460261) (← links)
- Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders (Q36830470) (← links)
- Therapeutic peptides and peptidomimetics (Q36877853) (← links)
- Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy (Q36969911) (← links)
- Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications (Q37049098) (← links)
- Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders (Q37191369) (← links)
- Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics (Q38128288) (← links)
- Liposomal vasoactive intestinal peptide. (Q40456475) (← links)
- Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors. (Q41121832) (← links)
- Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors (Q42539955) (← links)
- (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist (Q42816894) (← links)
- The effect of monocyclic and bicyclic analogs of human parathyroid hormone (hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats (Q43580099) (← links)
- Bronchodilating properties of the VIP receptor agonist Ro 25-1553 compared to those of formoterol on the guinea-pig isolated trachea (Q43800987) (← links)
- Efficient expression of isotopically labeled peptides for high resolution NMR studies: application to the Cdc42/Rac binding domains of virulent kinases in Candida albicans (Q44483496) (← links)
- A complete substitutional analysis of VIP for better tumor imaging properties. (Q52955891) (← links)
- Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R(8,15,21), L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors. (Q53507768) (← links)
- Assessment of the bioactive conformation of the vasoactive intestinal peptide by computational methods (Q63214163) (← links)
- Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor (Q73163603) (← links)
- Biodistribution of liposomal 131I-VIP in rat using gamma camera (Q73524509) (← links)
- Cyclization by a Specific Lactam Increases the Ability of Human Parathyroid Hormone (hPTH)-(1–31)NH2 to Stimulate Bone Growth in Ovariectomized Rats (Q73590756) (← links)
- Conformational study of vasoactive intestinal peptide by computational methods (Q73632681) (← links)
- A novel long-acting VIP analog in the guinea pig trachea in vitro (Q74419113) (← links)
- Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries (Q81857686) (← links)